CCA
MMSI icon

Conestoga Capital Advisors’s Merit Medical Systems MMSI Stock Holding History

Conestoga Capital Advisors’s Portfolio MMSI Stock Details MMSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$137M Sell
1,979,790
-187,723
-9% -$12.4M 2.99% 10
2026
Q1 		$149M Buy
2,167,513
+81,030
+4% +$6.33M 2.98% 11
2025
Q4 		$184M Sell
2,086,483
-98,782
-5% -$8.41M 3.09% 7
2025
Q3 		$182M Sell
2,185,265
-26,324
-1% -$2.29M 2.92% 9
2025
Q2 		$207M Sell
2,211,589
-53,584
-2% -$5.08M 3.05% 6
2025
Q1 		$239M Sell
2,265,173
-24,730
-1% -$2.55M 3.61% 5
2024
Q4 		$221M Buy
2,289,903
+755
+0% +$75.2K 2.94% 8
2024
Q3 		$226M Buy
2,289,148
+38,780
+2% +$3.55M 3.07% 11
2024
Q2 		$193M Buy
2,250,368
+75,885
+3% +$5.97M 2.9% 11
2024
Q1 		$165M Buy
2,174,483
+22,545
+1% +$1.74M 2.38% 16
2023
Q4 		$163M Buy
2,151,938
+11,995
+0.6% +$837K 2.45% 13
2023
Q3 		$148M Buy
2,139,943
+45,675
+2% +$3.29M 2.54% 13
2023
Q2 		$175M Buy
2,094,268
+2,866
+0.1% +$233K 2.78% 11
2023
Q1 		$155M Buy
2,091,402
+14,133
+0.7% +$992K 2.59% 10
2022
Q4 		$147M Sell
2,077,269
-5,393
-0.3% -$360K 2.74% 10
2022
Q3 		$118M Sell
2,082,662
-3,085
-0.1% -$178K 2.3% 16
2022
Q2 		$113M Sell
2,085,747
-450,185
-18% -$27.5M 2.06% 18
2022
Q1 		$169M Buy
2,535,932
+25,145
+1% +$1.51M 2.54% 10
2021
Q4 		$156M Buy
2,510,787
+117,795
+5% +$7.89M 2.03% 23
2021
Q3 		$172M Buy
2,392,992
+38,525
+2% +$2.61M 2.38% 13
2021
Q2 		$152M Buy
2,354,467
+23,030
+1% +$1.42M 2.2% 18
2021
Q1 		$140M Buy
2,331,437
+266,619
+13% +$15.3M 2.1% 20
2020
Q4 		$115M Buy
2,064,818
+18,573
+0.9% +$959K 1.83% 27
2020
Q3 		$89M Buy
2,046,245
+81,108
+4% +$3.67M 1.8% 25
2020
Q2 		$89.7M Buy
1,965,137
+371,285
+23% +$15M 1.95% 23
2020
Q1 		$49.8M Sell
1,593,852
-242,500
-13% -$8.64M 1.46% 37
2019
Q4 		$57.3M Sell
1,836,352
-209,535
-10% -$6M 1.38% 44
2019
Q3 		$62.3M Buy
2,045,887
+1,184,217
+137% +$47.9M 1.59% 33
2019
Q2 		$51.3M Buy
+861,670
New +$49.4M 1.28% 40

Other funds holding MMSI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Conestoga Capital Advisors's MMSI Position: Q2 2026 in Review

Conestoga Capital Advisors reduced its Merit Medical Systems (MMSI) stake by 8.7% in Q2 2026, selling an estimated $12.4M and leaving 1,979,790 shares worth $137M. The position accounts for 2.99% of the portfolio, ranked #10.

Conestoga Capital Advisors first reported a position in MMSI in Q2 2019 and has held it in 29 quarters since. The position peaked at $239M in Q1 2025. 404 funds tracked by Wall St. Rank hold MMSI as of Q2 2026.

  • Conestoga Capital Advisors held 1,979,790 shares of Merit Medical Systems worth $137M as of Q2 2026.
  • Conestoga Capital Advisors sold 187,723 Merit Medical Systems shares in Q2 2026, an estimated $12.4M.
  • Merit Medical Systems made up 2.99% of Conestoga Capital Advisors's portfolio in Q2 2026, its #10 holding.
  • Conestoga Capital Advisors first reported a position in Merit Medical Systems in Q2 2019 and has held it in 29 quarters since.
  • Conestoga Capital Advisors's Merit Medical Systems position peaked at $239M in Q1 2025.
  • 404 funds tracked by Wall St. Rank held Merit Medical Systems as of Q2 2026.

Based on Conestoga Capital Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.